Muhammad Alsabagh: The prognostic value of CD79a in pediatric ALL
Muhammad Alsabagh, Pediatric Oncology Assistant Lecturer and Specialist at National Cancer Institute – Cairo University, shared a post on LinkedIn:
“I’m thrilled to share that my abstract, ‘Prognostic Significance of CD79a Expression in Paediatric B-Cell Acute Lymphoblastic Leukaemia: Implications for Risk Stratification and Therapeutic Targeting,’ has been accepted for a poster presentation at the 17th SIOP Asia Congress 2025 in Riyadh, Saudi Arabia!
This work is a step forward in understanding the prognostic value of CD79a in pediatric ALL and its potential role in refining risk stratification and therapeutic decisions. I’m grateful for the opportunity to present at this prestigious platform and engage with fellow experts in pediatric oncology.
Looking forward to insightful discussions and collaborations at SIOP Asia 2025! See you in Riyadh!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023